AOTI (LSE:AOTI) EBIT: £4.00 Mil (TTM As of Dec. 2025)


LSE:AOTI AOTI Inc LSE:AOTI
21 GF Score
Price £0.62
! 8 Warning Signs
View Full Analysis

What is AOTI EBIT?

AOTI LSE:AOTI 21 EBIT is £4.00 Mil as of Dec. 2025. GuruFocus rates LSE:AOTI with a GF Score™ of 21/100. The stock has 8 warning signs investors should review.

AOTI's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was £2.60 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was £4.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. AOTI's annualized ROC % for the quarter that ended in Dec. 2025 was 18.21%. AOTI's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 41.35%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. AOTI's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.63%.


AOTI  (LSE:AOTI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

AOTI's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=5.314 * ( 1 - 0% )/( (27.763 + 30.586)/ 2 )
=5.314/29.1745
=18.21 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

AOTI's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=5.194/( ( (3.482 + max(8.302, 0)) + (3.05 + max(10.29, 0)) )/ 2 )
=5.194/( ( 11.784 + 13.34 )/ 2 )
=5.194/12.562
=41.35 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(14.547 + 3.672 + 0.029) - (1.727 + 0 + 8.219)
=8.302

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(16.251 + 3.796 + 0) - (0.925 + 0 + 8.832)
=10.29

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

AOTI's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=4.001/71.125
=5.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AOTI EBIT Related Terms


AOTI EBIT Historical Data

* Premium members only.

The historical data trend for AOTI's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AOTI EBIT Chart

AOTI Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
2.39 -0.14 -4.50 0.72 4.02

AOTI Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial -3.51 -2.08 2.81 1.40 2.60

LSE:AOTI vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, AOTI's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AOTI EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AOTI's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where AOTI's EV-to-EBIT falls into.


LSE:AOTI
21GF Score
AOTI Inc LSE:AOTI
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AOTI EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £4.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of £4.00 Mil mean?
AOTI (LSE:AOTI) has a EBIT of £4.00 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on AOTI.
Is AOTI's EBIT too high?
AOTI's current EBIT is £4.00 Mil. Overall, AOTI has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does AOTI's EBIT compare to ABT and SYK?
AOTI's EBIT of £4.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on AOTI. AOTI's current EBIT is £4.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AOTI stock overvalued right now?
AOTI (LSE:AOTI) has a current EBIT of £4.00 Mil. The current EBIT is £4.00 Mil. AOTI's overall GF Score™ is 21/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For AOTI (LSE:AOTI), the current EBIT is £4.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AOTI Business Description

Address 3512 Seagate Way, Suite 100, Oceanside, CA, USA, 92056
AOTI Inc is the design, manufacture and provision of topical oxygen therapy products and services for healthcare providers and patients with chronic wounds. These products and services enable patients to heal faster and more durably and healthcare providers to reduce the overall cost of care. The specific purposes of the Company are to patent, manufacture, rent, and sell medical devices to help resolve severe acute and chronic wounds for customers globally. The Company operates in one reportable segment, which comprises the development and sale of Creative medical devices for therapeutic care. The company's solutions includes Multi-Modality Oxygen Therapy, Extremity Chamber, Multi-Patch, Negative Pressure Wound Therapy.
21GF Score

Get the complete analysis for LSE:AOTI

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.62
Price